Oltmans Curtis Gale

CIK 00017149823 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001714982

Recent Transactions

36 trades

Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2026-02-02+170,000→ 170,000 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2025-12-15$12.92/sh−3,452→ 10,252 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2025-01-24+225,000→ 225,000 total
Award
AVENUE THERAPEUTICS, INC.$ATXI
Employee stock option (right to buy)
2024-09-23+30,000→ 30,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2024-01-26+150,000→ 150,000 total
Award
AVENUE THERAPEUTICS, INC.$ATXI
Employee stock option (right to buy)
2023-06-30+100,000→ 100,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2023-04-26+127,500→ 127,500 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2023-02-09+150,000→ 150,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-08-09+50,000→ 50,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-01-19+60,000→ 60,000 total
Award
AVENUE THERAPEUTICS, INC.$ATXI
Common Stock
2021-12-17+49,020→ 49,020 total
Gift
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-12-17−1,088→ 1,248 total
Purchase
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-06-28$9.01/sh+1,088→ 1,088 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-12-03+153,600→ 153,600 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-02-05$20.00/sh−40,000→ 15,021 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-02-05$8.94/sh+40,000→ 55,021 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-02-05−40,000→ 363,900 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-01-29$8.94/sh+11,100→ 15,021 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-01-29−11,100→ 403,900 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-01-25$8.94/sh+14,029→ 17,950 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-01-25−14,029→ 415,000 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-01-25$18.00/sh−14,029→ 3,921 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-01-18$8.94/sh+1,251→ 5,172 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-01-18−1,251→ 429,029 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-01-18$18.00/sh−1,251→ 3,921 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-01-15−19,720→ 430,280 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-01-15$18.06/sh−19,720→ 3,921 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-01-15$8.94/sh+19,720→ 23,641 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Restricted Stock Units
2018-12-16−7,000→ 21,000 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2018-12-16+7,000→ 7,000 total
Tax Payment
ARRAY BIOPHARMA INC
Common Stock
2018-12-16$15.97/sh−3,079→ 3,921 total
Award
ARRAY BIOPHARMA INC
Restricted Stock Units
2018-12-14+19,375→ 19,375 total
Award
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2018-12-14+116,250→ 116,250 total
Award
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2017-12-16+168,000→ 168,000 total
Award
ARRAY BIOPHARMA INC
Restricted Stock Units
2017-12-16+28,000→ 28,000 total
Award
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2017-08-15+450,000→ 450,000 total

Oltmans Curtis Gale

Recent Transactions

Companies

Recent Filings

Address